Ryght offers a powerful, global site network of AI digital twins, enabling users to identify, select, and activate the best clinical trial sites faster and more accurately than any other solution on the market. Their AI platform optimizes site performance, streamlines clinical trials from site selection to activation and enrollment, and accelerates time to market for biopharma clients.

The company is led by a team of seasoned entrepreneurs and healthcare professionals including Simon Arkell (Co-Founder and CEO), Alex Dickinson (Co-Founder and Chairman), and Dr. Chadi Nabhan (Chief Medical Officer and Head of Strategy). Backed by savvy investors, Ryght is committed to revolutionizing clinical trials using generative AI technologies to improve healthcare outcomes worldwide.

Ryght partners with leading academic medical centers like USC Keck School of Medicine and Emory University’s Winship Cancer Institute, enhancing clinical trial efficiency and patient matching using AI-powered digital twin technology. Their applications automate identification, selection, and activation of optimal sites globally, reducing delays, improving trial feasibility, and expanding access to novel therapies.

Headquartered in Laguna Beach, CA, Ryght is a privately held company founded in 2023 with a team of 11-50 employees. They maintain strategic partnerships with top technology providers such as Databricks, AWS, Microsoft Azure, and NVIDIA to support their AI-driven solutions.

Industry: Technology, Information and Internet
Company Size: 11-50 employees
Headquarters: Laguna Beach, CA
Type: Privately Held
Founded: 2023